169 related articles for article (PubMed ID: 15568893)
1. A standard weight descriptor for dose adjustment in the obese patient.
Duffull SB; Dooley MJ; Green B; Poole SG; Kirkpatrick CM
Clin Pharmacokinet; 2004; 43(15):1167-78. PubMed ID: 15568893
[TBL] [Abstract][Full Text] [Related]
2. Creatinine-clearance estimates for predicting gentamicin pharmacokinetic values in obese patients.
Leader WG; Tsubaki T; Chandler MH
Am J Hosp Pharm; 1994 Sep; 51(17):2125-30. PubMed ID: 7985687
[TBL] [Abstract][Full Text] [Related]
3. The influence of body size descriptors on the estimation of kidney function in normal weight, overweight, obese, and morbidly obese adults.
Park EJ; Pai MP; Dong T; Zhang J; Ko CW; Lawrence J; Crentsil V; Zhang L; Xu NN
Ann Pharmacother; 2012 Mar; 46(3):317-28. PubMed ID: 22395245
[TBL] [Abstract][Full Text] [Related]
4. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.
Nelson WK; Formica RN; Cooper DL; Schwartz PE; Rutherford TJ
J Oncol Pharm Pract; 2012 Sep; 18(3):323-32. PubMed ID: 22331238
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.
Kaag D
Lung Cancer; 2013 Jan; 79(1):54-8. PubMed ID: 23131495
[TBL] [Abstract][Full Text] [Related]
6. Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
Ekhart C; Rodenhuis S; Schellens JH; Beijnen JH; Huitema AD
Cancer Chemother Pharmacol; 2009 Jun; 64(1):115-22. PubMed ID: 18989671
[TBL] [Abstract][Full Text] [Related]
7. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.
Verhave JC; Fesler P; Ribstein J; du Cailar G; Mimran A
Am J Kidney Dis; 2005 Aug; 46(2):233-41. PubMed ID: 16112041
[TBL] [Abstract][Full Text] [Related]
8. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation.
Brown DL; Masselink AJ; Lalla CD
Ann Pharmacother; 2013; 47(7-8):1039-44. PubMed ID: 23757387
[TBL] [Abstract][Full Text] [Related]
9. [Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients].
Apperloo JJ; Gerlag PG; Beerenhout CH; Vader HL
Ned Tijdschr Geneeskd; 2007 May; 151(18):1016-23. PubMed ID: 17508688
[TBL] [Abstract][Full Text] [Related]
10. Estimating the glomerular filtration rate in obese adult patients for drug dosing.
Pai MP
Adv Chronic Kidney Dis; 2010 Sep; 17(5):e53-62. PubMed ID: 20727504
[TBL] [Abstract][Full Text] [Related]
11. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
Mahmood I
Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
[TBL] [Abstract][Full Text] [Related]
12. Impact of various body weights and serum creatinine concentrations on the bias and accuracy of the Cockcroft-Gault equation.
Winter MA; Guhr KN; Berg GM
Pharmacotherapy; 2012 Jul; 32(7):604-12. PubMed ID: 22576791
[TBL] [Abstract][Full Text] [Related]
13. Estimating creatinine clearance: a meta-analysis.
Wilhelm SM; Kale-Pradhan PB
Pharmacotherapy; 2011 Jul; 31(7):658-64. PubMed ID: 21923452
[TBL] [Abstract][Full Text] [Related]
14. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
[TBL] [Abstract][Full Text] [Related]
15. The performances of the Cockcroft-Gault, modification of diet in renal disease study and chronic kidney disease epidemiology collaboration equations in predicting gentamicin clearance.
Chin PK; Florkowski CM; Begg EJ
Ann Clin Biochem; 2013 Nov; 50(Pt 6):546-57. PubMed ID: 24045301
[TBL] [Abstract][Full Text] [Related]
16. Estimation of renal function in lung cancer patients.
Trobec K; Knez L; Meško Brguljan P; Cufer T; Lainščak M
Lung Cancer; 2012 Jun; 76(3):397-402. PubMed ID: 22177534
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Modification of Diet in Renal Disease Study and Cockcroft-Gault equations for sitagliptin dosing.
McFarland MS; Markley BM; Zhang P; Hudson JQ
J Nephrol; 2012; 25(4):515-22. PubMed ID: 21928236
[TBL] [Abstract][Full Text] [Related]
18. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease.
Kuan Y; Hossain M; Surman J; El Nahas AM; Haylor J
Nephrol Dial Transplant; 2005 Nov; 20(11):2394-401. PubMed ID: 16115853
[TBL] [Abstract][Full Text] [Related]
19. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.
Sinha J; Duffull SB; Green B; Al-Sallami HS
Clin Pharmacokinet; 2020 Apr; 59(4):475-483. PubMed ID: 31583612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
